Business Context and Reporting Period
Company: Legend Biotech Corporation
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date of Report: June 2, 2026
Context: The filing announces a late-breaking oral presentation of preliminary clinical data for the company's investigational therapy, LB2501, at the European Hematology Association (EHA) 2026 Congress.
Key Financial Metrics
This Form 6-K is a current report regarding a clinical data announcement and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes versus prior periods are reported in this document. The material update is the scheduled presentation of promising preliminary clinical data for LB2501, an in vivo CD19/CD20 dual-targeting CAR-T cell therapy for patients with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL).
Outlook, Risks, and Management Commentary
- Upcoming Event: Data will be presented June 11-14, 2026, in Stockholm, Sweden.
- Exhibits: The filing includes a press release (Exhibit 99.1) and an EHA abstract (Exhibit 99.2).
- Legal Status of Abstract: Exhibit 99.2 is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated.
- Risks: The filing describes the data as "preliminary" and "promising," implying standard clinical development risks associated with early-stage data interpretation.
Investor Verification Checklist
- Verify the full content of the EHA Abstract (Exhibit 99.2) for specific efficacy and safety numbers, as the filing text only summarizes the announcement.
- Confirm the exact date and time of the late-breaking oral presentation at the EHA 2026 Congress.
- Review the attached press release (Exhibit 99.1) for any additional management commentary or forward-looking statements not captured in the summary.
- Monitor subsequent filings for the full data readout and any impact on regulatory timelines for LB2501.